Heron Neutron Medical Corp.
Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and… Read more
Heron Neutron Medical Corp. (7799) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.118x
Based on the latest financial reports, Heron Neutron Medical Corp. (7799) has a cash flow conversion efficiency ratio of -0.118x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-157.10 Million) by net assets (NT$1.33 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Heron Neutron Medical Corp. - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Heron Neutron Medical Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Heron Neutron Medical Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Heron Neutron Medical Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Godfrey Phillips India Limited
NSE:GODFRYPHLP
|
0.089x |
|
SolarWinds Corp
NYSE:SWI
|
0.052x |
|
Tata Technologies Limited
NSE:TATATECH
|
0.037x |
|
MIRAIT ONE Corporation
PINK:MRHLF
|
N/A |
|
TKH Group NV
AS:TWEKA
|
0.168x |
|
Dorian LPG Ltd
NYSE:LPG
|
0.044x |
|
Air Transport Services Group Inc
NASDAQ:ATSG
|
0.090x |
|
Ternium Argentina SA
BA:TXAR
|
0.013x |
Annual Cash Flow Conversion Efficiency for Heron Neutron Medical Corp. (2022–2024)
The table below shows the annual cash flow conversion efficiency of Heron Neutron Medical Corp. from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.47 Billion | NT$-259.97 Million | -0.177x | -160.93% |
| 2023-12-31 | NT$806.40 Million | NT$-54.56 Million | -0.068x | +35.60% |
| 2022-12-31 | NT$590.48 Million | NT$-62.05 Million | -0.105x | -- |